Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ).
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has announced that its board of directors will meet on August 15, 2025, to consider and approve the unaudited financial results for the first half of the year ending June 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:0874) stock is a Sell with a HK$16.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company with limited liability established in the People’s Republic of China, operating in the pharmaceutical industry.
Average Trading Volume: 1,419,355
Technical Sentiment Signal: Buy
Current Market Cap: HK$45.19B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.